Who Owns OPRX?

OptimizeRx Corporation — Institutional Ownership & 13F Holdings

$6.21

+0.07 (+1.06%)

Market Cap

$120.3M

Shares Outstanding

18,762,200

Institutional Holders

87

Total Inst. Value

$100.1M

% of Float Held

81.3%

QoQ Holder Change

+3

Institutional data as of Q1 2025

New Positions

21

Closed Positions

18

Increased

24

Decreased

27

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Whetstone Capital Advisors, LLC$13.1M1,508,303
2BlackRock, Inc.$11.4M1,321,138
3ROYCE & ASSOCIATES LP$8.6M994,300
4VANGUARD GROUP INC$8.0M921,848
5BLAIR WILLIAM & CO/IL$5.5M631,031
6RICE HALL JAMES & ASSOCIATES, LLC$5.0M576,172
7KENNEDY CAPITAL MANAGEMENT LLC$4.1M478,404
8Parkman Healthcare Partners LLCNew$4.1M475,000
9DIMENSIONAL FUND ADVISORS LP$3.7M432,061
10GEODE CAPITAL MANAGEMENT, LLC$3.5M407,675

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold OPRX?

As of Q1 2025, 87 institutional investors report holding OPRX (OptimizeRx Corporation) in their 13F filings.

What percentage of OptimizeRx Corporation is owned by institutions?

Institutional investors hold approximately 81.3% of OptimizeRx Corporation's float as reported in SEC 13F filings.

Which hedge fund owns the most OPRX?

The largest institutional holder of OPRX is Whetstone Capital Advisors, LLC with $13.1M in shares.

Are institutions buying or selling OPRX?

This quarter, 21 institutions opened new positions in OPRX and 18 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.